Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis

1. STROM JL, EGEDE LE. The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. 2012 Dec; 12(6):769-81.10.1007/s11892-012-0317-0Search in Google Scholar

2. ZIMMET P, ALBERTI KG, SHAW J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414:782-787.10.1038/414782aSearch in Google Scholar

3. HOSSAIN P, KAWAR B, ELNAHAS M. Obesity and diabetes in the developing world - A growing challenge. N Engl J Med. 2007; 3 56:213-215.10.1056/NEJMp068177Search in Google Scholar

4. ANGULO P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346:1221-1231.10.1056/NEJMra011775Search in Google Scholar

5. YKI-JARVINEN H. Non-alcoholic fatty liver as a cause and cosequence of the metabolic syndrome. Lancet Diabetes Endocrinol. 2014; 2:901-910.10.1016/S2213-8587(14)70032-4Search in Google Scholar

6. DAOUSSI C, CASSON IF, GILL GV, MACFARLANE IA, WIELDING JPH, PINKNEI JH. Prevalence of obesity in type 2 diabetes in secondary care: Association with cardiovascular risk factors. Postgrad Med J. 2006; 82:280-284.10.1136/pmj.2005.039032Search in Google Scholar

7. STIUSO P, SCOGNAMIGLIO I, MUROLO M, FERRANTI P, DE SIMONE C, RIZZO MR, TUCCILLO C, CARAGLIA M, LOGUERCIO C, FEDERICO A. Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. Oxid Med Cell Longev. 2014; 2014:169216, 8 pages (1-8).10.1155/2014/169216Search in Google Scholar

8. RUST C, GORES GJ. Apoptosis and liver disease. Am J Med. 2000; 108:567-574.10.1016/S0002-9343(00)00370-3Search in Google Scholar

9. HALLIWELL B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996; 25:57-74.10.3109/107157696091456568814444Search in Google Scholar

10. ALBERTI KG, ECKEL RH, GRUNDY SM, ZIMMET PZ, CLEEMAN JI, DONATO KA, FRUCHART JC, JAMES WP, LORIA CM, SMITH SC JR; INTERNATIONAL DIABETES FEDERATION TASK FORCE ON EPIDEMIOLOGY AND PREVENTION; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; AMERICAN HEART ASSOCIATION; WORLD HEART FEDERATION; INTERNATIONAL ATHEROSCLEROSIS SOCIETY; INTERNATIONAL ASSOCIATION FOR THE STUDY OF OBESITY. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention. Circulation. 2009; 120:1640-1645.10.1161/CIRCULATIONAHA.109.19264419805654Search in Google Scholar

11. UKPDS ENGINE. Available at: http://www.dtu.ox.ac.uk/riskengine.Search in Google Scholar

12. AMERICAN DIABETES ASSOCIATION. Screening for Diabetes (Position Statement). Diabetes Care. 2010; 25 (Suppl. 1):S21-S24.10.2337/diacare.25.2007.S21Search in Google Scholar

13. AMERICAN DIABETES ASSOCIATION. Standards of Medical Care in Diabetes-2014 (Position Statement). Diabetes Care. January 2014; 37(Suppl. 1):S14-S80.10.2337/dc14-S014Search in Google Scholar

14. JENTZSCH A. M., BACHMANN H, Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med. 1996; 20(2):251-256.10.1016/0891-5849(95)02043-8Search in Google Scholar

15. FESTI D, SCHIUMERINI R, MARZI L, DI BIASE AR, MANDOLESI D, MONTRONE L, SCAIOLI E, BONATO G, MARCHESINI-REGGIANI G, COLECHIA A. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther. 2013 Feb; 37(4):392-400.10.1111/apt.12186Search in Google Scholar

16. YOUNOSSI ZM, JARRAR M, NUGENT C, et al. A novel diagnostic biomarker panel for obesity-related non-alcoholic steatohepatitis (NASH). Obes Surg. 2008; 18:1430-1437.10.1007/s11695-008-9506-ySearch in Google Scholar

17. GRIGORESCU M, CRISAN D, RADU C, GRIGORESCU MD, SPARCHEZ Z, SERBAN A. A novel pathophysiological-based panel of biomarkers for the diagnosis of non-alcoholic steatohepatitis. J of Physiol and Pharm. 2012; 63(4):347-353.Search in Google Scholar

18. KHOV N, SHARMA A and RILEY TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014 Jun 14; 20(22):6821-6825.10.3748/wjg.v20.i22.6821Search in Google Scholar

19. DALLE-DONNE I, ROSSI R, GIUSTARINI D, MILZANI A, COLOMBO R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta. 2003; 329(1-2):23-38.10.1016/S0009-8981(03)00003-2Search in Google Scholar

20. ECHOUFFO-TCHEUGUI JB, SARGEANT LA, PREVOST AT, WILLIAMS KM, BARLING RS, BUTLER R, FANSHAWE T, KINMONTH AL, WAREHAM NJ, GRIFFIN SJ. How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes? Diabet Med. 2008; 25(12):1433-1439.10.1111/j.1464-5491.2008.02600.x19046242Search in Google Scholar

21. WU YT, CHIEN CL, WANG SY, YANG WS, WU YW. Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. J Women Health. 2013; 22(5):439-444.10.1089/jwh.2012.4055365337623600438Search in Google Scholar

22. GAMBINO R, MUSSO G, CASSADER M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2011; 15(5):1325-1365.10.1089/ars.2009.305820969475Search in Google Scholar

23. ROMBOUTS K, MARRA F. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis. 2010; 28:229-235.10.1159/00028209420460917Search in Google Scholar